Development of a New Positron Emission Tomography Imaging Radioligand Targeting RIPK1 in the Brain and Characterization in Alzheimer's Disease
Authors:
Open Access
- 25 June 2024
- journal article
- research article
- Published by Wiley in Advanced Science
- Vol. 11 (32) , e2309021
Abstract
Targeting receptor‐interacting protein kinase 1 (RIPK1) has emerged as a promising therapeutic stratagem for neurodegenerative disorders, particularly Alzheimer's disease (AD). A positron emission tomography (PET) probe enabling brain RIPK1 imaging can provide a powerful tool to unveil the neuropathology associated with RIPK1. Herein, the development of a new PET radioligand, [11C]CNY‐10 is reported, which may enable brain RIPK1 imaging. [11C]CNY‐10 is radiosynthesized with a high radiochemical yield (41.8%) and molar activity (305 GBq/µmol). [11C]CNY‐10 is characterized by PET imaging in rodents and a non‐human primate, demonstrating good brain penetration, binding specificity, and a suitable clearance kinetic profile. It is performed autoradiography of [11C]CNY‐10 in human AD and healthy control postmortem brain tissues, which shows strong radiosignal in AD brains higher than healthy controls. Subsequently, it is conducted further characterization of RIPK1 in AD using [11C]CNY‐10‐based PET studies in combination with immunohistochemistry leveraging the 5xFAD mouse model. It is found that AD mice revealed RIPK1 brain signal significantly higher than WT control mice and that RIPK1 is closely related to amyloid plaques in the brain. The studies enable further translational studies of [11C]CNY‐10 for AD and potentially other RIPK1‐related human studies.Keywords
Funding Information
- Alzheimer's Drug Discovery Foundation (AG067916)
This publication has 49 references indexed in Scilit:
- Development of a potential PET probe for HDAC6 imaging in Alzheimer's diseaseActa Pharmaceutica Sinica B, 2022
- Pharmacological Inhibition of Necroptosis Protects from Dopaminergic Neuronal Cell Death in Parkinson’s Disease ModelsCell Reports, 2018
- Activation of Necroptosis in Multiple SclerosisCell Reports, 2015
- Alzheimer’s Disease Risk Genes and Mechanisms of Disease PathogenesisBiological Psychiatry, 2015
- Reducing HDAC6 ameliorates cognitive deficits in a mouse model for Alzheimer's diseaseEMBO Molecular Medicine, 2012
- cIAPs Block Ripoptosome Formation, a RIP1/Caspase-8 Containing Intracellular Cell Death Complex Differentially Regulated by cFLIP IsoformsMolecular Cell, 2011
- Receptor Interacting Protein Kinase-3 Determines Cellular Necrotic Response to TNF-αCell, 2009
- Structure–activity relationship study of [1,2,3]thiadiazole necroptosis inhibitorsBioorganic & Medicinal Chemistry Letters, 2007
- A novel approach for imaging brain–behavior relationships in mice reveals unexpected metabolic patterns during seizures in the absence of tissue plasminogen activatorNeuroImage, 2007
- Structure–activity relationship study of novel necroptosis inhibitorsBioorganic & Medicinal Chemistry Letters, 2005